About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 958469, 6 pages
http://dx.doi.org/10.1155/2014/958469
Research Article

Vancomycin-Resistant Enterococcus faecium Bacteremia in a Tertiary Care Hospital: Epidemiology, Antimicrobial Susceptibility, and Outcome

Section of Infectious Diseases, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2350, 90630000 Porto Alegre, RS, Brazil

Received 27 November 2013; Accepted 25 January 2014; Published 5 March 2014

Academic Editor: Abhijit Bal

Copyright © 2014 Regis G. Rosa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. C. Uttley, C. H. Collins, J. Naidoo, and R. C. George, “Vancomycin-resistant enterococci,” The Lancet, vol. 1, no. 8575-8576, pp. 57–58, 1988. View at Scopus
  2. B. E. Murray, “Vancomycin-resistant enterococcal infections,” The New England Journal of Medicine, vol. 342, no. 10, pp. 710–721, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. B. Edmond, J. F. Ober, D. L. Weinbaum et al., “Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection,” Clinical Infectious Diseases, vol. 20, no. 5, pp. 1126–1136, 1995. View at Scopus
  4. T. Peel, A. C. Cheng, T. Spelman, M. Huysmans, and D. Spelman, “Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia,” Clinical Microbiology and Infection, vol. 18, no. 4, pp. 388–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Iosifidis, I. Evdoridou, E. Agakidou et al., “Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit: epidemiology, molecular analysis and risk factors,” American Journal of Infection Control, vol. 41, no. 10, pp. 857–861, 2013. View at Publisher · View at Google Scholar
  6. Y. Kang, M. Vicente, S. Parsad et al., “Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients,” Transplant Infectious Disease, vol. 15, no. 5, pp. 466–473, 2013. View at Publisher · View at Google Scholar
  7. K. Hayakawa, D. Marchaim, E. T. Martin et al., “Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 5, pp. 2452–2458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. McKinnell, M. Patel, R. M. Shirley, D. F. Kunz, S. A. Moser, and J. W. Baddley, “Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents,” Epidemiology and Infection, vol. 139, no. 9, pp. 1342–1350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kraft, E. Mackler, P. Schlickman, K. Welch, and D. D. DePestel, “Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients,” Supportive Care in Cancer, vol. 20, pp. 1935–1936, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Vydra, R. M. Shanley, I. George et al., “Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation,” Clinical Infectious Diseases, vol. 55, pp. 764–770, 2012.
  11. S. Kraft, E. Mackler, P. Schlickman, K. Welch, and D. D. DePestel, “Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients,” Supportive Care in Cancer, vol. 20, pp. 1935–1936, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. D. Twilla, C. K. Finch, J. B. Usery, M. S. Gelfand, J. Q. Hudson, and J. E. Broyles, “Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin,” Journal of Hospital Medicine, vol. 7, no. 3, pp. 243–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. R. Facklam and M. D. Collins, “Identification of Enterococcus species isolated from human infections by a conventional test scheme,” Journal of Clinical Microbiology, vol. 27, no. 4, pp. 731–734, 1989. View at Scopus
  14. B. M. Willey, B. N. Kreiswirth, A. E. Simor et al., “Detection of vancomycin resistance in Enterococcus species,” Journal of Clinical Microbiology, vol. 30, no. 7, pp. 1621–1624, 1992. View at Scopus
  15. H. P. Endtz, N. Van Den Braak, A. Van Belkum et al., “Comparison of eight methods to detect vancomycin resistance in enterococci,” Journal of Clinical Microbiology, vol. 36, no. 2, pp. 592–594, 1998. View at Scopus
  16. R. Leclercq, E. Derlot, J. Duval, and P. Courvalin, “Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium,” The New England Journal of Medicine, vol. 319, no. 3, pp. 157–161, 1988. View at Scopus
  17. P. C. Iwen, D. M. Kelly, J. Linder, S. H. Hinrichs, E. A. Dominguez, and K. D. Patil, “Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 2, pp. 494–495, 1997. View at Scopus
  18. B. R. Meyers, “Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality,” Clinical Infectious Diseases, vol. 23, no. 4, pp. 760–766, 1996. View at Scopus
  19. A. K. Zaas, X. Song, P. Tucker, and T. M. Perl, “Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci,” Clinical Infectious Diseases, vol. 35, no. 10, pp. 1139–1146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. G. Bonora, M. Solbiati, E. Stepan et al., “Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage,” Journal of Clinical Microbiology, vol. 44, no. 3, pp. 1153–1155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Sabol, J. E. Patterson, J. S. Lewis II, A. Owens, J. Cadena, and J. H. Jorgensen, “Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 4, pp. 1664–1665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-H. Chou, N.-Y. Lee, H.-C. Lee, C.-M. Chang, C.-C. Lee, and W.-C. Ko, “Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan,” Journal of Microbiology, Immunology and Infection, vol. 45, pp. 221–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. B. Edmond, J. F. Ober, J. D. Dawson, D. L. Weinbaum, and R. P. Wenzel, “Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality,” Clinical Infectious Diseases, vol. 23, no. 6, pp. 1234–1239, 1996. View at Scopus
  24. Y.-T. Huang, C.-H. Liao, L.-J. Teng, and P.-R. Hsueh, “Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan,” Clinical Microbiology and Infection, vol. 14, no. 2, pp. 124–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. P. F. Smith, B. M. Booker, A. B. Ogundele, and P. Kelchin, “Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center,” Diagnostic Microbiology and Infectious Disease, vol. 52, no. 3, pp. 255–259, 2005. View at Publisher · View at Google Scholar · View at Scopus